# Shandong Keyuan Pharmaceutical Co., Ltd. – FDA Inspection, Jun 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/5f3452f6-d7ba-4d4f-80b0-8223d7584aee
Source feed: FDA_Inspections

> FDA inspection 1244249 of Shandong Keyuan Pharmaceutical Co., Ltd., June 14, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244249
- Company Name: Shandong Keyuan Pharmaceutical Co., Ltd.
- Inspection Date: 2024-06-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1064715 - 2018-08-02](https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/165ba864-3231-419e-94b0-f03f7b3a3d50)
- [FDA Inspection 927100 - 2015-04-10](https://www.keypedia.com/records/fda_inspections/shandong-keyuan-pharmaceutical-co-ltd/aaf4e02c-e992-459b-8c01-d0358a14b273)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)

Company: https://www.keypedia.com/companies/shandong-keyuan-pharmaceutical-co-ltd/971cc218-ba72-4cf7-a172-a4cb1627cb39

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c